DxS hires COO in continuing expansion plans
This article was originally published in Clinica
Jeff Devlin has been appointed COO of cancer diagnostics firm DxS (Manchester, UK). Mr Devlin joins from Shire Pharmaceuticals, where he was executive vice-president and an executive committee member. The company said it welcomed the addition of the marketing and physics graduate’s operations and strategy expertise, as the firm continued to expand.